SCHEDULE: Cormorant Asset Management Discloses 5.19% Stake in Adlai Nortye

Cormorant Asset Management, LP and Bihua Chen have reported beneficial ownership of 5.19% of Adlai Nortye Ltd.'s American Depositary Shares.

Summary

• Cormorant Asset Management, LP and Bihua Chen have jointly filed a Schedule 13G, indicating their beneficial ownership of Adlai Nortye Ltd. securities.
• The filing reports a total of 2,897,857 shares, representing 5.19% of the class of securities.
• These shares are held by Cormorant Funds, with Cormorant Global Healthcare Master Fund, LP having the right to receive or direct dividends and sale proceeds for over 5% of the shares.
• The reporting persons certify that the securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. It reports a significant ownership stake but provides no new operational or financial performance data for Adlai Nortye Ltd.

Positives

• Cormorant Asset Management, LP and Bihua Chen have disclosed a significant ownership stake, potentially indicating confidence in Adlai Nortye Ltd.'s future prospects.
• The filing confirms that the shares are held in the ordinary course of business, suggesting a standard investment strategy rather than a hostile takeover attempt.

Risks

• The filing does not explicitly mention any risks, but a significant ownership stake by an investment firm could lead to increased scrutiny or potential activist involvement if performance falters.
• The calculation of the percentage of class relies on outstanding share data from a Form 20-F filed April 10, 2026, and a private placement update from a Form 6-K filed February 3, 2026, which may be subject to change or further dilution.

Future Outlook

The filing itself does not contain forward-looking statements or guidance from Adlai Nortye Ltd. It solely reports ownership stakes by Cormorant Asset Management, LP and Bihua Chen.

Management Comments

• The filing should not be construed as an admission that any of the reporting persons is the beneficial owner of the shares reported herein.
• The Cormorant Funds have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares reported herein.
• Cormorant Global Healthcare Master Fund, LP, a Cormorant Fund, has the right to receive or the power to direct the receipt of dividends or the proceeds from the sale of more than 5% of the shares.
• The reporting persons certify that the securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors accumulating significant stakes in publicly traded companies. This filing indicates Cormorant Asset Management's interest in Adlai Nortye Ltd., a biotechnology company, aligning with typical investment patterns in the sector.

Stakeholder Impact

• Shareholders: The disclosure of a significant stake by an institutional investor may influence market perception and potentially lead to increased trading activity.
• Management: The company's management may need to engage with Cormorant Asset Management, LP regarding their investment strategy and the company's performance.
• Investors: Other investors will note this filing as an indicator of institutional interest in Adlai Nortye Ltd.

Next Steps

• Monitor future filings from Cormorant Asset Management, LP and Bihua Chen for any changes in their ownership stake.
• Observe Adlai Nortye Ltd.'s corporate actions and performance for potential strategic implications of this significant holding.

Key Dates

Keywords

Adlai Nortye Ltd., Cormorant Asset Management, LP, Bihua Chen, Schedule 13G, Beneficial Ownership, American Depositary Shares, Class A Ordinary Shares, Investment Adviser, SEC Filing